The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma

被引：3
|
作者：
Syed Maaz Tariq
Al-Ola Abdallah
Aaron Goodman
Douglas Sborov
Ghulam Rehman Mohyuddin
Alec Britt
机构：
[1] Jinnah Sindh Medical University,Division of Hematological Malignancies and Cellular Therapeutics
[2] University of Kansas Medical Center,Division of Hematology and Oncology
[3] University of California San Diego,Division of Hematology and Hematological Malignancies
[4] University of Utah,undefined
来源：
Clinical Hematology International | 2023年 / 5卷 / 2-3期
关键词：
Myeloma; Landscape; Lenalidomide; Maintenance;
D O I：
10.1007/s44228-023-00044-8
中图分类号：
学科分类号：
摘要：
Maintenance therapies in multiple myeloma improve survival after induction treatment. This study characterizes the strategies for maintenance therapy being employed in currently enrolling clinical trials for patients with multiple myeloma and highlights how high-risk myeloma patients may be assigned to maintenance strategies incongruent with current US guidelines.
引用
收藏
页码：170 / 176
页数：6
相关论文
共 50 条
  • [21] Initiation and maintenance of multiple myeloma
    Berenson, JR
    Bergsagel, PL
    Munshi, N
    SEMINARS IN HEMATOLOGY, 1999, 36 (01) : 9 - 13
  • [22] Maintenance therapy in multiple myeloma
    Harousseau, Jean-Luc
    HEMATOLOGY REPORTS, 2009, 1 (02) : 65 - 69
  • [23] Thalidomide maintenance in multiple myeloma
    Laubach, Jacob P.
    Richardson, Paul G.
    Anderson, Kenneth C.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (10) : 565 - 566
  • [24] Lenalidomide maintenance for multiple myeloma
    Brower, Vicki
    LANCET ONCOLOGY, 2012, 13 (06): : E238 - E238
  • [25] A Predictive Model of Overall Survival (OS) for Patients with Relapsed/Refractory Multiple Myeloma (MM) Enrolling in Phase I Clinical Trials
    Nooka, Amy K.
    Muppidi, Samatha
    Harvey, R. Donald
    Kaufman, Jonathan L.
    Langston, Amelia
    Lewis, Colleen
    Boise, Lawrence H.
    Flowers, Christopher R.
    Lonial, Sagar
    BLOOD, 2011, 118 (21) : 1691 - 1691
  • [26] Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs
    Gu, Xinyuan
    Tang, Wenjiao
    Zhang, Li
    Zheng, Yuhuan
    Pan, Ling
    Niu, Ting
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [27] Management of multiple myeloma: The changing landscape
    Reece, Donna E.
    BLOOD REVIEWS, 2007, 21 (06) : 301 - 314
  • [28] Landscape of Genomic Aberrations in Multiple Myeloma
    Gajendra, Smeeta
    Gupta, Ritu
    Rani, Lata
    Kaur, Gurvinder
    Dwivedi, Tanima
    Basnal, Atul
    Sharma, Om Dutt
    Sharma, Atul
    Kumar, Lalit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S541 - S541
  • [29] Posttransplantation Maintenance in Patients with Multiple Myeloma
    Facon, Thierry
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S55 - S56
  • [30] Maintenance Therapy in Multiple Myeloma: Novel Concepts in Clinical Practice from Recent Clinical Trials
    Gozzetti, Alessandro
    REVIEWS ON RECENT CLINICAL TRIALS, 2016, 11 (02) : 124 - 127
12345